BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22464072)

  • 1. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.
    Sparks AB; Struble CA; Wang ET; Song K; Oliphant A
    Am J Obstet Gynecol; 2012 Apr; 206(4):319.e1-9. PubMed ID: 22464072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.
    Norton ME; Brar H; Weiss J; Karimi A; Laurent LC; Caughey AB; Rodriguez MH; Williams J; Mitchell ME; Adair CD; Lee H; Jacobsson B; Tomlinson MW; Oepkes D; Hollemon D; Sparks AB; Oliphant A; Song K
    Am J Obstet Gynecol; 2012 Aug; 207(2):137.e1-8. PubMed ID: 22742782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.
    Ashoor G; Syngelaki A; Wagner M; Birdir C; Nicolaides KH
    Am J Obstet Gynecol; 2012 Apr; 206(4):322.e1-5. PubMed ID: 22464073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
    Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.
    Sparks AB; Wang ET; Struble CA; Barrett W; Stokowski R; McBride C; Zahn J; Lee K; Shen N; Doshi J; Sun M; Garrison J; Sandler J; Hollemon D; Pattee P; Tomita-Mitchell A; Mitchell M; Stuelpnagel J; Song K; Oliphant A
    Prenat Diagn; 2012 Jan; 32(1):3-9. PubMed ID: 22223233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic analysis for first-trimester trisomy 18 detection.
    Bahado-Singh RO; Akolekar R; Chelliah A; Mandal R; Dong E; Kruger M; Wishart DS; Nicolaides K
    Am J Obstet Gynecol; 2013 Jul; 209(1):65.e1-9. PubMed ID: 23535240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
    Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
    Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
    Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21.
    Jorgez CJ; Dang DD; Wapner R; Farina A; Simpson JL; Bischoff FZ
    Hum Reprod; 2007 Aug; 22(8):2267-72. PubMed ID: 17584747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy.
    Mao J; Wang T; Wang BJ; Liu YH; Li H; Zhang J; Cram D; Chen Y
    Clin Chim Acta; 2014 Jun; 433():190-3. PubMed ID: 24667696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18.
    Wataganara T; LeShane ES; Farina A; Messerlian GM; Lee T; Canick JA; Bianchi DW
    Hum Genet; 2003 Feb; 112(2):204-8. PubMed ID: 12522563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing.
    Verweij EJ; Jacobsson B; van Scheltema PA; de Boer MA; Hoffer MJ; Hollemon D; Westgren M; Song K; Oepkes D
    Prenat Diagn; 2013 Oct; 33(10):996-1001. PubMed ID: 23794121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
    Manotaya S; Xu H; Uerpairojkit B; Chen F; Charoenvidhya D; Liu H; Petcharaburanin N; Liu Y; Tang S; Wang X; Dansakul S; Thomsopa T; Gao Y; Zhang H; Xu H; Jiang H
    Prenat Diagn; 2016 Mar; 36(3):224-31. PubMed ID: 26748603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening].
    Liang D; Lin Y; Li H; Hu P; Xu ZF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):106-111. PubMed ID: 32146739
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.
    Lau TK; Chen F; Pan X; Pooh RK; Jiang F; Li Y; Jiang H; Li X; Chen S; Zhang X
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1370-4. PubMed ID: 22070770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.
    Yu SC; Chan KC; Zheng YW; Jiang P; Liao GJ; Sun H; Akolekar R; Leung TY; Go AT; van Vugt JM; Minekawa R; Oudejans CB; Nicolaides KH; Chiu RW; Lo YM
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8583-8. PubMed ID: 24843150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.
    Gerundino F; Giachini C; Contini E; Benelli M; Marseglia G; Giuliani C; Marin F; Nannetti G; Lisi E; Sbernini F; Periti E; Cordisco A; Colosi E; D'ambrosio V; Mazzi M; Rossi M; Staderini L; Minuti B; Pelo E; Cicatiello R; Maruotti GM; Sglavo G; Conti A; Frusconi S; Pescucci C; Torricelli F
    J Matern Fetal Neonatal Med; 2017 Mar; 30(6):710-716. PubMed ID: 27226231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.